Lumantas, Maria Leonora .

HRN: 16-93-80  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/24/2022
CEFUROXIME 750MG (VIAL)
11/24/2022
12/01/2022
IVTT
750mg
Q8Hrs
Breast CA
11/24/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/24/2022
12/01/2022
IVTT
600mg
Q8Hrs
Breast Cancer
Waiting Final Action 
11/24/2022
CEFTRIAXONE 1G (VIAL)
11/24/2022
11/30/2022
IV
2g
Q 24H
Ductal Carcinoma, L Breast
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: